De-implementation of URInary catheters in Neurosurgical patients during the operation and on the ward
- Conditions
- 1. Anterior skull base operations (transsphenoidal resection of pituitary gland tumours) and 2. Spinal fusion operations (spondylodesis)
- Registration Number
- NL-OMON20496
- Lead Sponsor
- W. C. Peul, MD, MPH, PhD, MBa Professor and Chair Neurosurgery Department of Neurosurgery Leiden University Medical Center E-mail: w.c.peul@lumc.nl Tel. +31715262109 Legally represented by: drs. Egbert Vos, Managing Director Division 3, LUMC, e.j.vos@lumc.nl
- Brief Summary
one yet
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 2000
To be included in the DURIN study the following conditions must be met for healthcare professionals:
-Age = 18 years;
-Must work as a neurosurgeon, neurosurgical resident, operation assistant, recovery nurse or neurosurgical ward nurse,
-For the satisfaction survey: informed consent is obtained,
-For the focus groups: informed consent is obtained.
To be included in the DURIN study the following conditions must be met for patients:
-Age = 18 years,
-Underwent transsphenoical pituitary gland tumour surgery or spinal fusion surgery (spondylodesis),
-For the satisfaction survey: informed consent is obtained.
A potential participant (healthcare professional) who meets any of the following criteria will be excluded from participation:
-For the satisfaction survey: no informed consent is obtained,
-For the focus groups: no informed consent is obtained.
A potential participant (patient) who meets any of the following criteria will be excluded from participation:
-Operation time > 4 hours;
-Preexisting bladder complications for which an IDUC is used pre-operatively;
-Peri- or postoperative neurological deficit (e.g. paresis);
-Preexisting psychological problems;
-Unable to understand and/or execute instructions from healthcare professionals;
-Not speaking fluent in Dutch
-For the satisfaction survey: no informed consent is obtained.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary study parameter will be the number of IDUCS that are placed during and/or after transsphenoidal pituitary gland tumour surgery and spinal fusion surgery (spondylodesis). Data corresponding to the IDUC placement (e.g. date of insertion, time of placement, location of insertion, reason of insertion and which discipline inserted the IDUC) will also be collected. Data will be obtained from the medical charts of patients who underwent these types of surgery from December 2018 until December 2022.
- Secondary Outcome Measures
Name Time Method